| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 144,911 | 150,884 | 139,228 | 168,211 | | Cost of Revenue | 254,811 |
-
|
-
| 96,566 | | | Gross Profit | (109,900) | 150,884 | 139,228 | 71,645 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (135,616) | 128,002 | 132,607 | 36,823 | | Non Recurring | (561) | 482,473 | 918 | 184,570 | | Others | 13,073 | 15,721 | 16,000 | 16,727 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,644 | (475,312) | (10,297) | (166,475) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,296 | (4,264) | (3,001) | (4,540) | | Earnings Before Interest And Taxes | 18,500 | (479,576) | (13,298) | (171,015) | | Interest Expense | 16,295 | 15,186 | 17,733 | 19,458 | | Income Before Tax | 2,205 | (494,762) | (31,031) | (190,473) | | Income Tax Expense | (7) | 15 | 300 | (7,616) | | Minority Interest | 336 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,212 | (494,777) | (31,331) | (182,857) | | | Non-recurring Events | | Discontinued Operations | (163) | (1,690) | (589) | 97 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,385 | (496,467) | (31,920) | (182,760) | | Preferred Stock And Other Adjustments | (222) | 79 | 143 |
-
| | | Net Income Applicable To Common Shares | $2,163 | ($496,388) | ($31,777) | ($182,760) |
|
0.22% Nasdaq 
Income Statement
